We exceeded our initial goals, but we want to make sure that everyone who believes that the future of diabetes care lies in next generation, AI-enabled, ultra low cost CGM powered by One Health Biosensing, has the opportunity to invest in this friends and family/community round, or increase their investment and participate in our success.

The team behind One Health CGM has pioneered some of the most innovative efforts in diabetes, digital health, and digital technology (One Drop, Welldoc, Bigfoot Biomedical, and Razorfish).

If you haven’t had the opportunity to join us by investing in One Health Biosensing, alongside over 130 others, this is your last chance and NOW is the time. INVEST HERE: (https://wefunder.com/onehealthbiosensing)

We didn’t invent CGM, but we are re-defining it.

The One Health CGM (continuous glucose monitor) is at the forefront of diabetes care and enables pain-free, needle-free glucose sensing in a daily disposable patch. We combined that with multi-modal sensing capabilities like heart rate monitoring, sleep tracking, activity tracking and the potential for multi-analyze sensing like ketones, lactic acid, and urea. It represents the next generation of CGM, it’s real, and we couldn’t be prouder in the team’s efforts. It’s also very cool. ; ) CHECK IT OUT: (https://wefunder.com/onehealthbiosensing)

Not only do investors in this community round get preferred pricing, but investors who join us enjoy these perks:

$500 - Receive your own One Health swag bag including a one-month trial of the One Health sensor system upon FDA clearance and launch

$1,500 - Your own One Health swag bag including a six-month trial of the One Health sensor system upon FDA clearance and launch

$ 2,500 - Wear a test sensor - pre-launch - and have lunch in NYC with CEO and founder, Jeff Dachis to discuss ideas about how to tackle the hard problems facing people with diabetes

No one is investing for the perks, but then again no one could have predicted that in an International Diabetes Federation event this past month it was estimated that in 2024, 589 million people (1 in 9) on the planet have diabetes. It was estimated that the cost of treating these people in 2024 exceeded $1 trillion USD representing 12% of all global health expenditures. It is estimated that this population and the cost to treat them will grow almost 50% to 850 million people and $2 trillion USD.

This is alarming.

CGM has proven to be one of the most effective and powerful tools in the arsenal for people to manage, treat, and reverse their diabetes, but less than 5% of people with diabetes have access to CGM. 

So, please take this opportunity now to join us on the journey to transform the lives of every single person on the planet with diabetes and be part of our success. INVEST HERE: (https://wefunder.com/onehealthbiosensing)

With gratitude and warm regards in good health,

Jeff Dachis, CEO, Founder

One Health Biosensing Inc.

Follow us here:

Instagram: https://instagram.com/onehealthbiosensing/

Facebook: https://facebook.com/profile.php?id=61566557262015

LinkedIn: https://linkedin.com/company/one-health-biosensing/

X/Twitter: https://x.com/OneHealthBio

URL: https://onehealthbiosensing.com